United States Tulathromycin Market Size, Share, Forecasts To 2035
According to a research report published by Spherical Insights & Consulting, the US Tulathromycin Market is Anticipated to hold a significant share by 2035, growing at a CAGR of 4.11% from 2025 to 2035.The US tulathromycin market focuses on producing, distributing, and utilizing this macrolide antibiotic, primarily used in veterinary medicine for treating respiratory infections in livestock, particularly in cattle and swine farming.